Morgan Stanley Lam Research · LRCX

Morgan Stanley Lowers Lam Research Price Target to $367

1 min read Reproduced verbatim
Rating
Overweight
Unchanged
Target
$367
from $404 (−9%)
Upside
+98%
LRCX at $185 today
Morgan Stanley and Lam Research logos

What the analyst said

Morgan Stanley analyst Shane Brett lowered the price target on Lam Research (NASDAQ: LRCX) to $367 (from $404) while maintaining an Overweight rating.

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Where the price stands

LRCX trades at $185. The 9 analysts who set a target in the last 3 months range from $290 to $400, with a median of $350. This $367 target is 5% above the median.

Since the note LRCX has moved −27% (from $252). 12-month window: day 98 of 365, closes on July 30, 2027.

Track record

This callOpen: LRCX has not reached $367 yet. This 12-month target is scored on July 30, 2027.

Firm track recordMorgan Stanley: 82% of its 49 targets at least a year old were reached within 12 months (#8 of 26 firms). Accuracy ranking →

Earnings reactionOne of 4 notes after Lam Research’s Jul 29 results: 0 raised · 4 cut · 0 kept. See every call →

Morgan Stanley on Lam Research

Morgan Stanley price targets on Lam Research

8 calls from January 29, 2026 to October 22, 2026. The target went from $244 to $339 (+39%). The rating stayed Buy.

Morgan Stanley targetLRCX share price
  1. October 22, 2026Target cut from $367 (−8%)Buy$339
  2. July 30, 2026 This noteTarget cut from $404 (−9%)Buy$367
  3. July 6, 2026Target raised from $331 (+22%)Buy$404
  4. May 18, 2026Target raised from $293 (+13%)Buy$331
  5. April 23, 2026Target raised from $260 (+13%)$293
  6. April 6, 2026Target raised from $254 (+2%)$260
  7. February 25, 2026Target raised from $244 (+4%)$254
  8. January 29, 2026Earliest call shown$244
Share

Other analysts on Lam Research

Lynx Equity Kept rating and price target Oct 28 $400maintained BernsteinBuy Cut price target −9%, kept rating Oct 22 $350from $385 UBSBuy Cut price target −6%, kept rating Oct 22 $400from $425 Bank of AmericaBuy Cut price target −10%, kept rating Oct 22 $345from $385 NeedhamBuy Cut price target −26%, kept rating Oct 22 $290from $390
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.